Skip Navigation

This Article
Right arrow Print PDF (214K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (140)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kubo, Y.
Right arrow Articles by Miyamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubo, Y.
Right arrow Articles by Miyamura, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1989, Vol. 17, No. 24 10367-10372
© 1989

Articles

A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan

Yoshihiro Kubo+, Kenji Takeuchi, Sumalee Boonmar§, Tohru Katayama1, Qui-Lim Choo2, George Kuo2, Amy J. Weiner2, Daniel W. Bradley3, Michael Houghton2, Izumu Saito and Tatsuo Miyamura*

Department of Enteroviruses, National Institute of Health, 2-10-35, Kamiosaki, Shinagawa-ku, Tokyo 141 1Department of Surgery, National Tokyo Chest Hospital 3-1-1, Takegaoka, Kiyose-shi, Tokyo 204, Japan 2Chiron Corporation 4560 Horton Street, Emeryville, CA 94608 3Centers for Disease Control 1600 Clifton Road NE, Atlanta, GA 30333, USA

*To whom correspondence should be addressed

Received October 10, 1989. Revised November 13, 1989. Accepted November 13, 1989.

Recently, a cDNA from the hepatitis C virus (HCV) RNA genome has been 1solated in the USA from a chronicallyinfected chimpanzee. In order to isolate HCV cDNA derived from human material, RNA was extracted from plasma of a Japanese blood donor implicated in post-transfusion non-A, non-B hepatitis and HCV cDNA was synthesized and amplified by the PCR method using HCV-specific oligonucleotide primers. The cDNA fragment, 583 nucleotides long, showed 79.8% homology at the nucleotide level and 92.2% homology at the amino acid level compared with the prototype HCV cDNA. These results provides further evidence to show that HCV is closely assoclated with the development of post transfusion non-A, non-B hepatitis.

+Present address: Department of Neurophysiology, Tokyo Metropolitan Institute for Neurosciences, 2-6, Musashidai, Fuchu-shi, Tokyo 183, Japan

§On leave from Department of Medical sciences, Viruses Research Institute, National Institute of Health, Nonthaburi 11000, Thailand


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Shirai, T. Arichi, M. Chen, M. Nishioka, K. Ikeda, H. Takahashi, N. Enomoto, T. Saito, M. E. Major, T. Nakazawa, et al.
T Cell Recognition of Hypervariable Region-1 from Hepatitis C Virus Envelope Protein with Multiple Class II MHC Molecules in Mice and Humans: Preferential Help for Induction of Antibodies to the Hypervariable Region
J. Immunol., January 1, 1999; 162(1): 568 - 576.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. Tsukuma, T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, T. Kitamura, K. Nakanishi, I. Fujimoto, A. Inoue, H. Yamazaki, et al.
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
N. Engl. J. Med., June 24, 1993; 328(25): 1797 - 1801.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.